• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型嵌合溶菌酶在耐甲氧西林和甲氧西林敏感金黄色葡萄球菌菌株的皮肤去定植方面优于莫匹罗星。

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.

机构信息

Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10065, USA.

出版信息

Antimicrob Agents Chemother. 2011 Feb;55(2):738-44. doi: 10.1128/AAC.00890-10. Epub 2010 Nov 22.

DOI:10.1128/AAC.00890-10
PMID:21098252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3028755/
Abstract

Staphylococcus aureus is a major human pathogen responsible for a number of serious and sometimes fatal infections. One of its reservoirs on the human body is the skin, which is known to be a source of invasive infection. The potential for an engineered staphylococcus-specific phage lysin (ClyS) to be used for topical decolonization is presented. We formulated ClyS into an ointment and applied it to a mouse model of skin colonization/infection with S. aureus. Unlike the standard topical antibacterial agent mupirocin, ClyS eradicated a significantly greater number of methicillin-susceptible S. aureus (MSSA) and -resistant S. aureus (MRSA) bacteria: a 3-log reduction with ClyS as opposed to a 2-log reduction with mupirocin in our model. The use of ClyS also demonstrated a decreased potential for the development of resistance by MRSA and MSSA organisms compared to that from the use of mupirocin in vitro. Because antibodies may affect enzyme function, we tested antibodies developed after repeated ClyS exposure for their effect on ClyS killing ability. Our results showed no inhibition of ClyS activity at various antibody titers. These data demonstrate the potential of developing ClyS as a novel class of topical antimicrobial agents specific to staphylococcus.

摘要

金黄色葡萄球菌是一种主要的人类病原体,可导致许多严重甚至致命的感染。人体上的一个储存库是皮肤,众所周知,皮肤是侵袭性感染的来源。本文提出了一种针对金黄色葡萄球菌的工程化特异性噬菌体溶素(ClyS)用于局部去定植的潜力。我们将 ClyS 制成软膏,并将其应用于金黄色葡萄球菌皮肤定植/感染的小鼠模型。与标准局部抗菌剂莫匹罗星不同,ClyS 能更有效地消除大量耐甲氧西林金黄色葡萄球菌(MSSA)和耐甲氧西林金黄色葡萄球菌(MRSA)细菌:我们的模型中,ClyS 可使细菌减少 3 个对数级,而莫匹罗星则减少 2 个对数级。与莫匹罗星相比,ClyS 的使用还表明,MRSA 和 MSSA 细菌产生耐药性的潜力降低。由于抗体可能影响酶的功能,我们测试了在重复 ClyS 暴露后产生的抗体对 ClyS 杀伤能力的影响。我们的结果表明,在不同的抗体滴度下,ClyS 活性没有受到抑制。这些数据表明,开发 ClyS 作为一种新型的针对金黄色葡萄球菌的局部抗菌药物具有潜力。

相似文献

1
A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.一种新型嵌合溶菌酶在耐甲氧西林和甲氧西林敏感金黄色葡萄球菌菌株的皮肤去定植方面优于莫匹罗星。
Antimicrob Agents Chemother. 2011 Feb;55(2):738-44. doi: 10.1128/AAC.00890-10. Epub 2010 Nov 22.
2
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.新型嵌合溶菌酶与苯唑西林协同作用,可预防耐甲氧西林金黄色葡萄球菌感染。
Antimicrob Agents Chemother. 2010 Apr;54(4):1603-12. doi: 10.1128/AAC.01625-09. Epub 2010 Jan 19.
3
Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.美国金黄色葡萄球菌对局部用药的敏感性:一项哨点研究。
Clin Ther. 2014 Jun 1;36(6):953-60. doi: 10.1016/j.clinthera.2014.04.003. Epub 2014 May 15.
4
The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.莫匹罗星和外用氯己定治疗后金黄色葡萄球菌去定植的持续存在:对需要多次或延迟手术的患者的影响。
J Arthroplasty. 2012 Jun;27(6):870-6. doi: 10.1016/j.arth.2012.01.010. Epub 2012 Mar 6.
5
Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.利用广谱嵌合溶菌酶与莫匹罗星协同对抗金黄色葡萄球菌引起的皮肤感染并延缓莫匹罗星耐药性的产生。
Microbiol Spectr. 2023 Jun 15;11(3):e0505022. doi: 10.1128/spectrum.05050-22. Epub 2023 May 1.
6
An Ointment Consisting of the Phage Lysin LysGH15 and Apigenin for Decolonization of Methicillin-Resistant from Skin Wounds.一种含有噬菌体溶菌酶 LysGH15 和芹菜素的软膏,用于皮肤创伤中耐甲氧西林的定植。
Viruses. 2018 May 6;10(5):244. doi: 10.3390/v10050244.
7
Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.新型重组溶菌酶软膏对从伤口和烧伤处分离出的耐甲氧西林金黄色葡萄球菌具有广泛抗菌活性。
Arch Microbiol. 2023 Mar 4;205(4):104. doi: 10.1007/s00203-023-03434-x.
8
Prevalence of methicillin resistant and mupirocin-resistant Staphylococcus aureus strains among medical students of Medical University in Warsaw.华沙医科大学医学生中甲氧西林耐药和莫匹罗星耐药金黄色葡萄球菌菌株的流行情况。
Przegl Epidemiol. 2019;73(1):39-48. doi: 10.32394/pe.73.05.
9
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model.合成噻唑化合物在耐甲氧西林金黄色葡萄球菌(MRSA)皮肤感染小鼠模型中的体内外抗菌评价
PLoS One. 2015 Nov 4;10(11):e0142321. doi: 10.1371/journal.pone.0142321. eCollection 2015.
10
In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.月桂酸单酯制剂对金黄色葡萄球菌活性的体外和体内评价。
Antimicrob Agents Chemother. 2005 Aug;49(8):3187-91. doi: 10.1128/AAC.49.8.3187-3191.2005.

引用本文的文献

1
An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: and assessment of its efficacy.一种不含抗生素的细菌素与肽聚糖水解酶的抗菌组合及其疗效评估。
Appl Environ Microbiol. 2025 Jun 24:e0243324. doi: 10.1128/aem.02433-24.
2
Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and Recent Applications.抗耐药葡萄球菌属的噬菌体衍生内溶素:特性、抗菌活性及近期应用综述
Infect Dis Ther. 2025 Jan;14(1):13-57. doi: 10.1007/s40121-024-01069-z. Epub 2024 Nov 16.
3
Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.靶向细菌细胞壁的药物:对抗革兰氏阳性病原体的工具。
Molecules. 2024 Aug 27;29(17):4065. doi: 10.3390/molecules29174065.
4
Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence.利用人工智能从未鉴定噬菌体的“暗物质”中发现抗菌溶菌酶。
Adv Sci (Weinh). 2024 Aug;11(32):e2404049. doi: 10.1002/advs.202404049. Epub 2024 Jun 20.
5
An Exploratory Review of the Potential of Lytic Proteins and Bacteriophages for the Treatment of Tuberculosis.溶菌蛋白和噬菌体治疗结核病潜力的探索性综述
Microorganisms. 2024 Mar 12;12(3):570. doi: 10.3390/microorganisms12030570.
6
Staphylococcus aureus colonisation and strategies for decolonisation.金黄色葡萄球菌定植与去定植策略。
Lancet Microbe. 2024 Jun;5(6):e606-e618. doi: 10.1016/S2666-5247(24)00040-5. Epub 2024 Mar 19.
7
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae.内溶素 EN572-5 可作为治疗无乳链球菌引起的尿路感染的一种替代方法。
Appl Microbiol Biotechnol. 2024 Dec;108(1):79. doi: 10.1007/s00253-023-12949-8. Epub 2024 Jan 8.
8
A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective.噬菌体来源的内溶素在食源性病原体和食品安全中的应用综述:最新进展、挑战及未来展望
Front Microbiol. 2023 Oct 6;14:1259210. doi: 10.3389/fmicb.2023.1259210. eCollection 2023.
9
Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria.金黄色葡萄球菌噬菌体 52 溶菌素具有抗生物膜活性和广谱抗革兰氏阳性菌活性。
Protein J. 2023 Oct;42(5):596-606. doi: 10.1007/s10930-023-10145-1. Epub 2023 Aug 27.
10
Structural and biochemical insights into the bacteriophage PlyGRCS endolysin targeting methicillin-resistant Staphylococcus aureus (MRSA) and serendipitous discovery of its interaction with a cold shock protein C (CspC).针对耐甲氧西林金黄色葡萄球菌 (MRSA) 的噬菌体 PlyGRCS 溶菌酶的结构和生化见解,以及与冷休克蛋白 C (CspC) 偶然发现的相互作用。
Protein Sci. 2023 Sep;32(9):e4737. doi: 10.1002/pro.4737.

本文引用的文献

1
Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.腹膜透析患者出口部位应用莫匹罗星:五年经验。
Ren Fail. 2010 Jan;32(3):356-61. doi: 10.3109/08860221003611703.
2
Interventions for preventing infectious complications in haemodialysis patients with central venous catheters.预防中心静脉导管血液透析患者感染性并发症的干预措施。
Cochrane Database Syst Rev. 2010 Jan 20(1):CD006894. doi: 10.1002/14651858.CD006894.pub2.
3
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.新型嵌合溶菌酶与苯唑西林协同作用,可预防耐甲氧西林金黄色葡萄球菌感染。
Antimicrob Agents Chemother. 2010 Apr;54(4):1603-12. doi: 10.1128/AAC.01625-09. Epub 2010 Jan 19.
4
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.预防金黄色葡萄球菌鼻腔携带者的手术部位感染。
N Engl J Med. 2010 Jan 7;362(1):9-17. doi: 10.1056/NEJMoa0808939.
5
Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.莫匹罗星预防腹膜透析患者出口部位感染和腹膜炎。
Nephrol Dial Transplant. 2010 Feb;25(2):587-92. doi: 10.1093/ndt/gfp411. Epub 2009 Aug 13.
6
Mupirocin resistance.莫匹罗星耐药性
Clin Infect Dis. 2009 Sep 15;49(6):935-41. doi: 10.1086/605495.
7
Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.耐甲氧西林金黄色葡萄球菌定植的局部治疗:对感染风险的影响
Infect Control Hosp Epidemiol. 2009 Jul;30(7):623-32. doi: 10.1086/597550.
8
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects.用莫匹罗星进行金黄色葡萄球菌的鼻腔去定植:优势、劣势及未来前景
J Antimicrob Chemother. 2009 Jul;64(1):9-15. doi: 10.1093/jac/dkp159. Epub 2009 May 18.
9
Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review.耐甲氧西林金黄色葡萄球菌携带的根除:一项系统评价
Clin Infect Dis. 2009 Apr 1;48(7):922-30. doi: 10.1086/597291.
10
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.莫匹罗星软膏预防鼻腔携带者金黄色葡萄球菌感染
Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD006216. doi: 10.1002/14651858.CD006216.pub2.